🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 7

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 7 of 9
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
Nov 9, 2025 at 1:45 AM#31
roxy_nash said:
Resolved, and the thing that resolved it was the least interesting suggestion in the thread.

I read this differently from roxy_nash, on substance rather than tone. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

21 19JakeSmashed95, NauseaFreeNow, SteveThurs and 18 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Nov 18, 2025 at 6:25 PM#32
roxy_nash said:
Resolved, and the thing that resolved it was the least interesting suggestion in the thread.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

I would rather be corrected than agreed with, if it comes to it.

22 20Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 19 others
Reply Quote Save Share Report
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
Nov 28, 2025 at 11:10 AM#33
roxy_nash said:
Resolved, and the thing that resolved it was the least interesting suggestion in the thread.

This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.

23 21DoseLogDan, SleepFixSam, PurityPaulOR and 20 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Dec 8, 2025 at 4:01 AM#34

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

24 22tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 21 others
Reply Quote Save Share Report
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Dec 17, 2025 at 8:58 PM#35
Dr.SleepRoch said:
Start from the measurement rather than the conclusion.

Same experience, arrived at from the opposite direction.

25 23tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 22 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register